Company Performance Metrics
- Erik Ni: Chief Technology Officer
- Phillip Alexander: Co-Founder & CRO
IPMD, Inc. is the creator of EchoAI, a human-centered agentic emotional AI platform dedicated to healing where technology, humanity, and dignity meet. Founded in 2016 at UC Berkeley, IPMD has developed the world’s most advanced Human-Centered Agentic Emotional AI, achieving a 96% emotion recognition accuracy. Trained on over 130,000 hours of
multimodal emotional interaction data, EchoAI interprets complex human affects with high-fidelity performance, consistently outperforming industry benchmarks from major technology providers.
EchoBloom Initiative, a transformative "Human Care" model designed to build inclusive systems of healing and resilience for marginalized communities. EchoBloom serves as a clinical data engine, combining generative AI art creation with advanced emotional AI to enable deep self-expression and restore communication for individuals with "unspoken emotional worlds." This initiative establishes a dedicated pathway to transform EchoAI into an FDA-regulated medical device, ensuring that empathetic technology is validated for safety and effectiveness.
Proven Excellence & Strategic Partnerships Validated by prestigious global institutions, IPMD’s technology won first place at the Texas Children's Hospital Healthcare Hackathon and successfully completed a high-impact AI Tech Sprint with the U.S. Department of Veterans Affairs.
IPMD is a proud member of the NVIDIA Inception program, a Google Cloud Technology Partner, and a participant in the Microsoft for Startups and IBM Startup programs. By bridging the gap between cognitive science and agentic AI, IPMD is pioneering a future where technology restores dignity and emotional health for families and caregivers worldwide.
